SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-354752
Filing Date
2013-09-03
Accepted
2013-09-03 06:31:26
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d572953d10q.htm 10-Q 482604
2 EX-10.8 d572953dex108.htm EX-10.8 10479
3 EX-31.1 d572953dex311.htm EX-31.1 9044
4 EX-31.2 d572953dex312.htm EX-31.2 9106
5 EX-32.1 d572953dex321.htm EX-32.1 4847
  Complete submission text file 0001193125-13-354752.txt   5496599

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT omed-20130630.xml EX-101.INS 612405
7 XBRL TAXONOMY EXTENSION SCHEMA omed-20130630.xsd EX-101.SCH 36734
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE omed-20130630_cal.xml EX-101.CAL 44362
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE omed-20130630_def.xml EX-101.DEF 138907
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE omed-20130630_lab.xml EX-101.LAB 303370
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omed-20130630_pre.xml EX-101.PRE 209292
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Filer) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35993 | Film No.: 131073836
SIC: 2834 Pharmaceutical Preparations